Asia Pacific Anti-infective Agents Market Size & Outlook
Asia Pacific anti-infective agents market, 2018-2030 (US$M)
Related Markets
Asia Pacific anti-infective agents market highlights
- The Asia Pacific anti-infective agents market generated a revenue of USD 33,277.8 million in 2024.
- The market is expected to grow at a CAGR of 3.6% from 2025 to 2030.
- In terms of segment, antibacterials was the largest revenue generating type in 2024.
- Antifungals is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 33,277.8 million |
| Market revenue in 2030 | USD 40,617.7 million |
| Growth rate | 3.6% (CAGR from 2025 to 2030) |
| Largest segment | Antibacterials |
| Fastest growing segment | Antifungals |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibacterials, Antivirals, Antifungals |
| Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 24.6% of the global anti-infective agents market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 40,617.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anti-infective Agents Market Scope
Anti-infective Agents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific anti-infective agents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antibacterials was the largest segment with a revenue share of 64.51% in 2024. Horizon Databook has segmented the Asia Pacific anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
Collaborative efforts and strategic partnerships are also on the rise, exemplified by recent license agreements that grant development and commercialization rights to companies specializing in antiinfective research.
In April 2023, Asahi Kasei Pharma received approval to produce and market Cresemba Capsule 40 mg in Japan as a new formulation for treating invasive fungal infections. Regulatory bodies in the region are increasingly streamlining approval processes for innovative treatments, further enhancing the market landscape.
Reasons to subscribe to Asia Pacific anti-infective agents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific anti-infective agents market databook
-
Our clientele includes a mix of anti-infective agents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific anti-infective agents market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific anti infective agents market size, by country, 2018-2030 (US$M)
Asia Pacific Anti-infective Agents Market Outlook Share, 2024 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
